Québec City, Canada, March 31, 2010 – Æterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), (the “Company”) a late-stage drug development company specialized in oncology and endocrinology, today announced that its Senior Vice President and Chief Medical Officer, Paul Blake, MD, will present a corporate overview at BioFinance on Wednesday, April 7, 2010, at 10:00 am (eastern time), in the Trinity IV room, of the Toronto Marriott Eaton Centre, in Toronto, Canada.
About Æterna Zentaris Inc.
Æterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at www.aezsinc.com.
